Oxycodone

被引:221
作者
Kalso, E
机构
[1] Helsinki CHU, Dept Anesthesia & Intens Care Med, FIN-00029 Helsinki, Finland
[2] Univ Helsinki, FIN-00014 Helsinki, Finland
关键词
oxycodone; oxymorphone;
D O I
10.1016/j.jpainsymman.2005.01.010
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Oxycodone has been in clinical use since 1917. Parenteral oxycodone was used mainly for the treatment of acute postoperative pain whereas combinations, for example, oxycodone and acetaminophen, were used for moderate pain. Since the introduction of controlled-release oxycodone, it has been used to manage cancer-related pain and chronic non-cancer-related pain problems. Controlled studies have been performed in Postoperative pain, cancer pain, osteoarthritis-related pain, and neuropathic pain due to postherpetic neuralgia and diabetic neuropathy. The phormacodynamic effects of oxycodone are typical of a mu-opioid agonist. Oxycodone closely resembles morphine but it has some distinct differences, particularly in its pharmacokinetic profile. Being an old drug, the basic pharmacology of oxycodone has been a neglected field of research. (c) 2005 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:S47 / S56
页数:10
相关论文
共 63 条
[1]   Comparison of epidural morphine and oxycodone for pain after abdominal surgery [J].
Backlund, M ;
Lindgren, L ;
Kajimoto, Y ;
Rosenberg, PH .
JOURNAL OF CLINICAL ANESTHESIA, 1997, 9 (01) :30-35
[2]   DETERMINATION OF OXYCODONE AND A MAJOR METABOLITE IN URINE BY ELECTRON-CAPTURE GLC [J].
BASELT, RC ;
STEWART, CB .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1978, 2 (03) :107-109
[3]  
BEAVER WT, 1978, J PHARMACOL EXP THER, V207, P92
[4]   COMPARISONS OF ANALGESIC EFFECTS OF ORAL AND INTRAMUSCULAR OXYMORPHONE AND OF INTRAMUSCULAR OXYMORPHONE AND MORPHINE IN PATIENTS WITH CANCER [J].
BEAVER, WT ;
WALLENSTEIN, SL ;
HOUDE, RW ;
ROGERS, A .
JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 17 (04) :186-198
[5]  
BEAVER WT, 1978, J PHARMACOL EXP THER, V207, P101
[6]   Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain [J].
Bruera, E ;
Belzile, M ;
Pituskin, E ;
Fainsinger, R ;
Darke, A ;
Harsanyi, Z ;
Babul, N ;
Ford, I .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3222-3229
[7]  
Caldwell JR, 1999, J RHEUMATOL, V26, P862
[8]   MU RECEPTOR-BINDING OF SOME COMMONLY USED OPIOIDS AND THEIR METABOLITES [J].
CHEN, ZR ;
IRVINE, RJ ;
SOMOGYI, AA ;
BOCHNER, F .
LIFE SCIENCES, 1991, 48 (22) :2165-2171
[9]   Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain [J].
Citron, ML ;
Kaplan, R ;
Parris, WCV ;
Croghan, MK ;
Herbst, LH ;
Rosenbluth, RJ ;
Reder, RF ;
Slagle, NS ;
Buckley, BJ ;
Kaiko, RF .
CANCER INVESTIGATION, 1998, 16 (08) :562-571
[10]   Relative potency of controlled-release oxycodone and controlled-release morphine in a postoperative pain model [J].
Curtis, GB ;
Johnson, GH ;
Clark, P ;
Taylor, R ;
Brown, J ;
O'Callaghan, R ;
Shi, M ;
Lacouture, PG .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 55 (06) :425-429